National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 9, 2011, Pages 2011-2021

  Blanco, Jorge ^a   Mora, Azucena ^a   Mamani, Rosalia ^a   López, Cecilia ^a   Blanco, Miguel ^a   Dahbi, Ghizlane ^a   Herrera, Alexandra ^a   Blanco, Jesús E ^a   Alonso, María Pilar ^b   García Garrote, Fernando ^b   Chaves, Fernando ^c   Orellana, María Angeles ^c   Martínez Martínez, Luis ^d,e   Calvo, Jorge ^d,e   Prats, Guillem ^f,g   Larrosa, María Nieves ^f,g   lez López, Juan José Gonzá ^f,g   López Cerero, Lorena ^h   Rodríguez Baño, Jesús ^h,i   Pascual, Alvaro ^h,i  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Hospital Lucus Augusti   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e UNIVERSITY OF CANTABRIA   (Spain)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

ⁱ UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Antimicrobial resistance; E. coli; ExPEC

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL VIRULENCE; ESCHERICHIA COLI; HEALTH SURVEY; INTESTINE INFECTION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; SPAIN;

EID: 80051681158     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr235     Document Type: Article

References (35)

1. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273-81.
2. Coque TM, Novais A, Carattoli A et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum b-lactamase CTX-M-15. Emerg Infect Dis 2008; 14: 195-200.
3. Woodford N, Ward ME, Kaufmann ME et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum b-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735-43.
4. Cagnacci S, Gualco L, Debbia E et al. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 2008; 46: 2605-12.
5. Leflon-Guibout V, Blanco J, Amaqdouf K et al. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 2008; 46: 3900-5.
6. Johnson JR, Menard M, Johnston B et al. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 2009; 53: 2733-9.
7. Blanco M, Alonso MP, Nicolas-Chanoine MH et al. Molecular epidemiology of Escherichia coli producing extended-spectrum β-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2009; 63: 1135-41.
8. Johnson JR, Johnston B, Clabots C et al. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010; 51: 286-94.
9. Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010; 35: 316-21.
10. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011; 66: 1-14.
11. Mora A, Herrera A, Mamani R et al. Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates. Appl Environ Microbiol 2010; 76: 6991-7.
12. Coelho A, Mora A, Mamani R et al. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J Antimicrob Chemother 2011; 66: 517-26.
13. Prats G, Navarro F, Mirelis B et al. Escherichia coli serotype O15:K52:H1 as a uropathogenic clone. J Clin Microbiol 2000; 38: 201-9.
14. Johnson JR, Stell AL, O'Bryan TT et al. Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe. J Clin Microbiol 2002; 40: 1913-23.
15. Olesen B, Scheutz F, Menard M et al. Three-decade epidemiological analysis of Escherichia coli O15:K52:H1. J Clin Microbiol 2009; 47: 1857-62.
16. Mora A, Blanco M, López C et al. Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int J Antimicrob Agents 2011; 37: 16-21.
17. Manges AR, Johnson JR, Foxman B et al. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001; 345: 1007-13.
18. Tartof SY, Solberg OD, Manges AR et al. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol 2005; 43: 5860-4.
19. Johnson JR, Murray AC, Kuskowski MA et al. Distribution and characteristics of Escherichia coli clonal group A. Emerg Infect Dis 2005; 11: 141-5.
20. Manges AR, Tabor H, Tellis P et al. Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg Infect Dis 2008; 14: 1575-83.
21. Díaz MA, Hernández-Bello JR, Rodríguez-Baño J et al. Diversity of Escherichia coli strains producing extended-spectrum b-lactamases in Spain: second nationwide study. J Clin Microbiol 2010; 48: 2840-5.
22. Cuevas O, Oteo J, Lázaro E et al. Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid. J Antimicrob Chemother 2011; 66: 664-9.
23. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
24. Leflon-Guibout V, Jurand C, Bonacorsi S et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 2004; 48: 3736-42.
25. Clermont O, Dhanji H, Upton M et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 2009; 64: 274-7.
26. Johnson JR, Owens K, Sabate M et al. Rapid and specific detection of the O15:K52:H1 clonal group of Escherichia coli by gene-specific PCR. J Clin Microbiol 2004; 42: 3841-3.
27. Johnson JR, Owens K, Manges AR et al. Rapid and specific detection of Escherichia coli clonal group A by gene-specific PCR. J Clin Microbiol 2004; 42: 2618-22.
28. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-8.
29. Martinez-Medina M, Mora A, Blanco M et al. Similarity and divergence among adherent-invasive Escherichia coli and extraintestinal pathogenic E. coli strains. J Clin Microbiol 2009; 47: 3968-79.
30. Guinée PAM, Jansen WH, Wadström Tet al. Escherichia coli associated with neonatal diarrhoea in piglets and calves. In: Leeuw PW, Guinée PAM, eds. Laboratory Diagnosis in Neonatal Calf and Pig Diarrhoea: Current Topics in Veterinary and Animal Science. The Hague: Martinus-Nijhoff, 1981; 126-62.
31. Mora A, López C, Dabhi G et al. Extraintestinal pathogenic Escherichia coli O1:K1:H7/NM from human and avian origin: detection of clonal groups B2 ST95 and D ST59 with different host distribution. BMC Microbiol 2009; 9: 132.
32. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181: 261-72.
33. Manning SD, Zhang L, Foxman B et al. Prevalence of known P-fimbrial G alleles in Escherichia coli and identification of a new adhesion class. Clin Diagn Lab Immunol 2001; 8: 637-40.
34. Johnson JR, Murray AC, Gajewski A et al. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother 2003; 47: 2161-8.
35. Clermont O, Lavollay M, Vimont S et al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 2008; 61: 1024-8.